Close Menu
healthylife7.comhealthylife7.com

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Fashion’s mystery man Margiela sells off his archives | ABS

    July 10, 2026

    Comedian Nam Hyo-na loses nearly 30kg with obesity treatment drug… “It must never be used for cosmetic purposes” [New Story]

    July 10, 2026

    St. Mary’s Residential Community opens wellness gym for residents with developmental disabilities

    July 10, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Fashion’s mystery man Margiela sells off his archives | ABS
    • Comedian Nam Hyo-na loses nearly 30kg with obesity treatment drug… “It must never be used for cosmetic purposes” [New Story]
    • St. Mary’s Residential Community opens wellness gym for residents with developmental disabilities
    • What to eat while taking a GLP
    • Gov. Green Signs Legislation to Expand Access to Healthcare and Relieve Medical Debt
    • Matt Damon reveals gruelling details for ‘getting jacked’ ahead of ‘strong and lean’ role
    • /C O R R E C T I O N –
    • Why you’re always hungry—even after eating, according to a nutrition scientist
    Facebook X (Twitter) Instagram
    healthylife7.comhealthylife7.com
    • Home
    • Fitness
    • Health
    • Nutrition
    • Lifestyle
    • Conditions
    • Mental Health
    • Weight Loss
    • Wellness Tips
    Friday, July 10
    healthylife7.comhealthylife7.com
    Home»Wellness Tips»Could GLP-1 Drugs Reduce Breast Cancer Risk?
    Wellness Tips

    Could GLP-1 Drugs Reduce Breast Cancer Risk?

    stamilhstgr0518@gmail.comBy stamilhstgr0518@gmail.comJuly 8, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Could GLP-1 Drugs Reduce Breast Cancer Risk?
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention

    As multiple studies presented at the American Society of Clinical Oncology’s annual meeting linked GLP-1 drugs to lower rates of breast cancer, better survival outcomes when combined with standard breast cancer treatment, and decreased odds of the cancer spreading in several major tumor types

    While the findings are still early, they could inspire further research to determine if GLP-1s’ benefits could extend into the biology of cancer itself

    However, I spoke with several medical experts who view these findings as a signal – not a reason to prescribe GLP-1s for cancer prevention without additional evidence

    “These findings are raising important questions, but they should not be interpreted to mean that GLP-1 medications prevent or treat cancer,” said Dr. Monique Gary, a breast surgical oncologist in the St. Luke’s University Health Network

    “These drugs are not approved for cancer treatment, they come with their own risks and considerations, and we still have much to learn about what may be driving the associations we’re seeing,” Gary told FI

    Though GLP-1s were initially developed to treat type 2 diabetes, they’re widely used for weight management today, as they mimic a hormone that regulates blood sugar and appetite

    Researchers are now studying whether their impact on weight, inflammation, and other metabolic pathways could affect cancer outcomes, given that excess weight – especially post-menopause – is known to increase breast cancer risk

    One retrospective analysis of 110,000 women ages 45-80 found that those taking GLP-1s were 30% less likely to develop breast cancer than those who didn’t, while another study of 27,000 breast cancer patients found that adding these drugs to standard cancer treatment was associated with a 30% lower death risk

    Meanwhile, a third study of 12,000 patients with breast, lung, bowel, or liver cancer found that individuals taking weight-loss drugs were 38-50% less likely to develop stage-four forms of their respective diseases than those who weren’t

    This consistency across studies has caught clinicians’ attention, though it’s important to remember perhaps the most important research tenet when considering these findings: that correlation does not equal causation

    Dr. Andrew Shapiro, a board-certified surgeon and Medical Director of the Comprehensive Breast Center at Wellington Regional Medical Center believes the research question has become less about if there’s a signal and more about what it means

    “We are seeing enough consistency across studies that I suspect we will ultimately identify a meaningful role for GLP-1 therapies somewhere in the breast cancer continuum. The challenge is defining where they fit, which patients benefit most, and whether the effect is related to weight loss, metabolic health, inflammation, direct biologic effects, or a combination of factors,” he told FI

    For now, Shapiro says he’d be comfortable recommending GLP-1s to patients already facing obesity, diabetes, and/or other metabolic risk factors – but not specifically as a breast cancer prevention strategy just yet.breast cancer, unity, women, prevention, health, awareness, breast cancer, breast cancer, breast cancer, breast cancer, breast cancer

    While some experts believe the cancer-related benefits are largely tied to weight loss, which can reduce cancer risk on its own, others suspect GLP-1s may have additional effects like lowering chronic inflammation or impacting tumor-related pathways

    “A central question arising from this research is the ‘how’ and ‘why.’ We know obesity is a significant risk factor for cancer, so the substantial weight loss induced by these drugs is undoubtedly a major contributor to the reduced risk,” said Dr. Deena Graham, a breast medical oncologist at John Theurer Cancer Center – Hackensack University Medical Center

    “However, the data also suggests that the drugs’ anti-inflammatory properties and other metabolic effects might be inhibiting tumor growth directly, independent of weight loss,” Graham told FI

    Dr. Michael Shockley, a board-certified surgeon at Advanced Surgical Physicians, also highlighted weight loss and inflammation as likely drivers but remains open to the possibility that GLP-1s could help for other reasons

    “This new data should be considered in this individualized approach and discussion, but I do not think a causative relationship has been established where the overall guidelines to managing these patients should be changed,” Shockley told FI

    At the moment, these studies appear to have raised more questions than they’ve answered

    However, they demonstrate that GLP-1s are increasingly solidifying their place in a broader conversation, which may go beyond obesity and diabetes to encompass both cancer prevention and survival. Only time – and additional evidence – will tell

    Food for Thought Leadership

    Food retail is undergoing a fundamental transformation, and few people have a better vantage point than the SupermarketGuru Phil Lempert. In this episode ofFood for Thought Leadership, Lempert joins FI’s Chris Campbell to discuss the forces reshaping grocery, from inflation and private label growth to changing consumer expectations around health, wellness, and transparency

    Breast could drugs GLP1 reduce
    stamilhstgr0518@gmail.com
    • Website

    Related Posts

    Study Reveals Losing Just One Hour of Sleep Can Lead to Weight Gain

    July 9, 2026

    Oh!mino Survey Finds GLP-1 Muscle Loss Concerns Drive New Focus on Preserving Muscle While Dieting

    July 9, 2026

    Public Perceptions Around Weight Loss Drugs in the UK Revealed

    July 9, 2026
    Leave A Reply Cancel Reply

    Health
    Lifestyle

    Fashion’s mystery man Margiela sells off his archives | ABS

    By stamilhstgr0518@gmail.comJuly 10, 20260

    Fashion’s mystery man Margiela sells off his archives HEADLINES: | HEADLINES: | Health, Beauty, and Fashion Fashion’s mystery man Margiela sells off his archives Adam Plowright Agence France-Presse Published July 10, 2026 08:20 AM PHT ADVERTISEMENT ADVERTISEMENT Read More: Martin Margiela| Paris| France| belgium| fashion| auction| margiela| Agence France-Presse ABS-CBN Newsletter Your go-toerviews, and updates…

    Comedian Nam Hyo-na loses nearly 30kg with obesity treatment drug… “It must never be used for cosmetic purposes” [New Story]

    July 10, 2026

    St. Mary’s Residential Community opens wellness gym for residents with developmental disabilities

    July 10, 2026

    What to eat while taking a GLP

    July 10, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Fitness

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026

    What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

    July 6, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    Welcome to HealthyLife7.com, your trusted source for reliable health, wellness, fitness, and lifestyle information. Our mission is to help people make informed decisions about their health by providing clear, practical, and easy-to-understand content.

    At HealthyLife7.com, we believe that good health starts with the right knowledge. Whether you're looking for healthy eating tips, fitness advice, mental wellness strategies, weight management guidance, or information about common health conditions, our goal is to deliver valuable content that supports a healthier lifestyle.

    Fitness

    Fashion’s mystery man Margiela sells off his archives | ABS

    July 10, 2026

    Comedian Nam Hyo-na loses nearly 30kg with obesity treatment drug… “It must never be used for cosmetic purposes” [New Story]

    July 10, 2026

    St. Mary’s Residential Community opens wellness gym for residents with developmental disabilities

    July 10, 2026
    Health

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthylife7.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.